Effects of dopaminergic treatment on putaminal dopamine turnover measured with 18F-Dopa-PET in Parkinson's disease

被引：0
|
作者：
Wolz, M. [1 ]
Beuthien-Baumann, B. [2 ]
Loehle, M. [1 ]
Herting, B. [1 ]
Oehme, L. [2 ]
van den Hoff, J. [3 ]
Perick, M. [2 ]
Kotzerke, J. [2 ]
Reichmann, H. [1 ]
Storch, A. [1 ]
机构：
[1] Tech Univ Dresden, Dept Neurol, Dresden, Germany
[2] Tech Univ Dresden, Dept Nucl Med, Dresden, Germany
[3] Forschungszentrum Dresden Rossendorf, Positron Emiss Tomog Div, Dresden, Germany
来源：
PARKINSONISM & RELATED DISORDERS | 2009年 / 15卷
关键词：
D O I：
10.1016/S1353-8020(09)70222-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1.100
引用
收藏
页码：S54 / S55
页数：2
相关论文
共 50 条
  • [41] Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease -: A 3D [18F]dopa-PET study
    Rakshi, JS
    Uema, T
    Ito, K
    Bailey, DL
    Morrish, PK
    Ashburner, J
    Dagher, A
    Jenkins, IH
    Friston, KJ
    Brooks, DJ
    BRAIN, 1999, 122 : 1637 - 1650
  • [42] Effect of a potential neurotrophic drug on the progression of dopaminergic nigro-striatal lesions assessed by 18F-Dopa PET imaging in Parkinson's disease
    Ribeiro, Maria J.
    Stoessl, A. J.
    Brooks, David J.
    Leenders, Klaus
    Marttila, Reijo
    Thobois, Stephane
    Lostao, Javier Arbizu
    Vingerhoets, Francois
    Truffinet, Philippe
    Remy, Philippe
    NEUROLOGY, 2008, 70 (11) : A437 - A437
  • [43] Comparison of 18F-DOPA and 18F-DTBZ for PET/CT Imaging of Idiopathic Parkinson Disease
    Shi, Xinchong
    Yang, Yang
    Jiang, Lulu
    Chen, Jinhua
    Yi, Chang
    Luo, Ganhua
    Wu, Lei
    Chu, Jianmin
    Wang, Jian
    Chen, Ling
    Zhang, Xiangsong
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (11) : 931 - 935
  • [44] Corticostriatal covariance patterns of 6–[18F]fluoro–L–dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease
    V. Kaasinen
    R. P. Maguire
    H.–P. Hundemer
    K. L. Leenders
    Journal of Neurology, 2006, 253 : 340 - 348
  • [45] 18F-DTBZ PET tracks dopaminergic degeneration in patients with Parkinson disease
    Heather Wood
    Nature Reviews Neurology, 2014, 10 (6) : 305 - 305
  • [46] Striatal dopaminergic depletion in initial unilateral Parkinson's Disease: a 18F-FDOPA PET study
    Arbizu, J
    Rodriguez-Fraile, M
    Rodriguez-Oroz, MC
    Marti-Climent, JM
    Obeso, JA
    Richter, JA
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S370 - S370
  • [47] Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET
    Nurmi, E
    Bergman, J
    Eskola, O
    Solin, O
    Vahlberg, T
    Sonninen, P
    Rinne, JO
    SYNAPSE, 2003, 48 (03) : 109 - 115
  • [48] Increase in dopamine turnover occurs early in Parkinson's disease:: Evidence from a new modeling approach to PET 18F-fluorodopa data
    Sossi, V
    de la Fuente-Fernández, I
    Holden, JE
    Doudet, DJ
    McKenzie, J
    Stoessl, AJ
    Ruth, TJ
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2002, 22 (02): : 232 - 239
  • [49] 6-[F-18]FLUORO-L-DOPA PROBES DOPAMINE TURNOVER RATES IN CENTRAL DOPAMINERGIC STRUCTURES
    BARRIO, JR
    HUANG, SC
    MELEGA, WP
    YU, DC
    HOFFMAN, JM
    SCHNEIDER, JS
    SATYAMURTHY, N
    MAZZIOTTA, JC
    PHELPS, ME
    JOURNAL OF NEUROSCIENCE RESEARCH, 1990, 27 (04) : 487 - 493
  • [50] Striatal D2 dopamine receptor status in Parkinson's disease:: An [18F]dopa and [11C]raclopride PET study
    Dentresangle, C
    Veyre, L
    Le Bars, D
    Pierre, C
    Lavenne, F
    Pollak, P
    Guerin, J
    Froment, JC
    Brousolle, E
    MOVEMENT DISORDERS, 1999, 14 (06) : 1025 - 1030
12345